Tarsus Pharmaceuticals, Inc. TARS Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s common stock shares issued?
- Tarsus Pharmaceuticals, Inc. (TARS) reported common stock shares issued of 43M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s common stock shares issued changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s common stock shares issued increased by 2.4% year-over-year, from 42M to 43M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s common stock shares issued?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s common stock shares issued has grown at a 15.7% compound annual growth rate (CAGR), from 20.5M to 42.6M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.